Abilify Aripiprazole 5mg Tablets

Abilify Aripiprazole 5mg Tablets

Abilify Aripiprazole 5mg Tablets are a pharmaceutical product designed for the treatment of various psychiatric conditions. Aripiprazole, the active ingredient, is an atypical antipsychotic that helps to restore the balance of certain natural chemicals in the brain (neurotransmitters).

Product Specifications:
- Active Ingredient: Aripiprazole 5mg
- Formulation: Oral tablets
- Packaging: Blister packs or bottles
- Recommended Storage: Store at room temperature, away from moisture and heat

Common Applications:
- Schizophrenia in adults and adolescents (13-17 years)
- Bipolar I disorder (acute manic and mixed episodes, and as maintenance treatment)
- Adjunctive treatment for major depressive disorder in adults
- Irritability associated with autistic disorder in pediatric patients (6-17 years)
- Treatment of Tourette's disorder in pediatric patients (6-18 years)

User Groups:
- Adults diagnosed with schizophrenia or bipolar disorder
- Adolescents with schizophrenia, bipolar disorder, or irritability associated with autism
- Children with Tourette's disorder

Supplier Overview:
Otsuka Pharmaceutical Co., Ltd. is a global healthcare company with a strong focus on pharmaceuticals and nutraceuticals. As the developer of Abilify Aripiprazole, Otsuka is a leader in the field of central nervous system disorders. Their commitment to innovation and extensive research in mental health treatments positions them as an authority in the psychiatric medication space. Otsuka's dedication to improving the lives of patients worldwide through novel and effective therapeutic products makes them a trusted supplier in the pharmaceutical industry.